|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
188,370,000 |
Market
Cap: |
16.70(B) |
Last
Volume: |
1,778,607 |
Avg
Vol: |
1,398,026 |
52
Week Range: |
$76.22 - $99 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 1018 |
Guru Rank Value : 0.1 |
Guru Occurances : 4 |
|
|
|
|
|
|
|
Company Profile BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
3,625 |
Total Buy Value |
$0 |
$0 |
$0 |
$314,469 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
1 |
Total Shares Sold |
714 |
160,302 |
276,407 |
571,147 |
Total Sell Value |
$64,260 |
$13,335,112 |
$23,824,420 |
$53,365,721 |
Total People Sold |
1 |
5 |
6 |
7 |
Total Sell Transactions |
1 |
11 |
22 |
49 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Fuchs Henry J |
EVP, Chief Medical Officer |
|
2010-05-03 |
4 |
OE |
$11.05 |
$9,205 |
D/D |
833 |
22,275 |
|
- |
|
Aselage Steve |
EVP, Chief Business Officer |
|
2010-04-30 |
4 |
A |
$11.64 |
$17,827 |
D/D |
1,532 |
21,387 |
|
- |
|
Bienaime Jean Jacques |
Chief Executive Officer |
|
2010-04-30 |
4 |
A |
$11.64 |
$21,260 |
D/D |
1,827 |
50,567 |
|
- |
|
Baffi Robert |
EVP, Technical Operations |
|
2010-04-30 |
4 |
A |
$11.64 |
$15,744 |
D/D |
1,353 |
54,540 |
|
- |
|
Davis George Eric |
SVP, General Counsel |
|
2010-04-30 |
4 |
A |
$11.64 |
$16,943 |
D/D |
1,456 |
21,908 |
|
- |
|
Fuchs Henry J |
EVP, Chief Medical Officer |
|
2010-04-30 |
4 |
A |
$13.23 |
$19,072 |
D/D |
1,442 |
21,442 |
|
- |
|
Wood Mark |
VP, Human Resources |
|
2010-04-12 |
4 |
S |
$23.81 |
$22,314 |
D/D |
(937) |
8,081 |
|
- |
|
Wood Mark |
VP, Human Resources |
|
2010-04-12 |
4 |
OE |
$14.39 |
$13,483 |
D/D |
937 |
9,018 |
|
- |
|
Wood Mark |
VP, Human Resources |
|
2010-04-05 |
4 |
S |
$24.63 |
$7,684 |
D/D |
(312) |
8,081 |
|
- |
|
Wood Mark |
VP, Human Resources |
|
2010-04-05 |
4 |
OE |
$14.00 |
$4,368 |
D/D |
312 |
8,393 |
|
- |
|
Fuchs Henry J |
EVP, Chief Medical Officer |
|
2010-04-01 |
4 |
S |
$24.00 |
$139,974 |
D/D |
(5,833) |
20,000 |
|
- |
|
Fuchs Henry J |
EVP, Chief Medical Officer |
|
2010-04-01 |
4 |
OE |
$11.05 |
$64,455 |
D/D |
5,833 |
25,833 |
|
- |
|
Wood Mark |
VP, Human Resources |
|
2010-03-12 |
4 |
S |
$22.17 |
$20,793 |
D/D |
(938) |
8,081 |
|
- |
|
Wood Mark |
VP, Human Resources |
|
2010-03-12 |
4 |
OE |
$14.39 |
$13,498 |
D/D |
938 |
9,019 |
|
- |
|
Baffi Robert |
EVP, Technical Operations |
|
2010-03-10 |
4 |
S |
$22.52 |
$3,691,020 |
D/D |
(163,888) |
60,588 |
|
- |
|
Baffi Robert |
EVP, Technical Operations |
|
2010-03-10 |
4 |
OE |
$22.00 |
$3,605,536 |
D/D |
163,888 |
224,476 |
|
- |
|
Wood Mark |
VP, Human Resources |
|
2010-03-08 |
4 |
S |
$22.14 |
$6,930 |
D/D |
(313) |
8,081 |
|
- |
|
Wood Mark |
VP, Human Resources |
|
2010-03-08 |
4 |
OE |
$14.00 |
$4,382 |
D/D |
313 |
8,394 |
|
- |
|
Klein Joseph III |
Director |
|
2010-03-08 |
4 |
S |
$22.12 |
$221,227 |
D/D |
(10,000) |
35,000 |
|
- |
|
Aselage Steve |
EVP, Chief Business Officer |
|
2010-03-08 |
4 |
S |
$22.11 |
$532,526 |
D/D |
(24,090) |
19,855 |
|
- |
|
Aselage Steve |
EVP, Chief Business Officer |
|
2010-03-08 |
4 |
OE |
$7.16 |
$172,484 |
D/D |
24,090 |
55,361 |
|
- |
|
Aselage Steve |
EVP, Chief Business Officer |
|
2010-03-05 |
4 |
S |
$21.95 |
$140,831 |
D/D |
(6,416) |
43,945 |
|
- |
|
Aselage Steve |
EVP, Chief Business Officer |
|
2010-03-04 |
4 |
S |
$21.50 |
$107,500 |
D/D |
(5,000) |
50,361 |
|
- |
|
Aselage Steve |
EVP, Chief Business Officer |
|
2010-03-03 |
4 |
S |
$21.00 |
$210,000 |
D/D |
(10,000) |
31,271 |
|
- |
|
Aselage Steve |
EVP, Chief Business Officer |
|
2010-03-02 |
4 |
S |
$21.00 |
$210,000 |
D/D |
(10,000) |
41,271 |
|
- |
|
1213 Records found
|
|
Page 31 of 49 |
|
|